TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GILD

Gilead Sciences Inc

Healthcare · Drug Manufacturers - General

150.60$ +0.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Gilead Sciences Inc (GILD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 3,573 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GILD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,755 2,169 2,219 1,325 4,309 2,975 1,757 827 4,108 3,327 2,544 3,573 13,552
684 688 690 694 690 693 696 691 686 687 689 -689 1,373
202 201 187 210 216 222 209 225 230 230 218 -218 460
-1,549 -543 -459 -1,546 642 483 -1,033 -2,014 -297 -604 -711 711 -901
122 215 105 130 141 147 104 107 147 205 117 117 586
-229 -727 -2,207 -307 -710 -225 -415 -2,116 -427 -1,835 1,770 -10,347 -10,839
953 943 990 972 983 973 1,010 994 1,005 994 1,040 1,029 4,068
-300 -150 -400 -100 -300 -350 -730 -527 -435 -230 -419 -355 -1,439
-112 3,457 -1,762 -9.0 -9.0 -8.0 -2,766 4,068 1,285
-1,519 -1,099 -1,361 -2,953 -1,379 2,260 -3,426 -1,567 -1,489 -1,263 -4,239 2,344 -4,647
1.0 380 -1,367 -1,946 2,265 4,954 -2,065 -2,782 2,186 234 64 -4,449 -1,965
1,633 1,954 2,114 1,195 4,168 2,828 1,653 720 3,961 3,121 2,427 3,690 13,199

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?